Publication | Closed Access

Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial

Hematological MalignancyBone Marrow FailureHematologyClinical TrialsMyeloid NeoplasiaDose-ranging TrialPharmacotherapyLong-term ExtensionPhase 2MedicineAplastic AnemiaHealth Sciences